On April 26, 2023 Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company focused on the discovery and development of innovative therapeutics for fibro-inflammatory diseases with high unmet need, reported that the company will participate in the Aegis Virtual Conference being held May 2–May 4, 2023 (Press release, Chemomab, APR 26, 2023, View Source [SID1234630518]). Chemomab management will present a corporate overview on Wednesday, May 3, 2023.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Aegis 2023 Virtual Investor Conference
Date:
May 3, 2023
Time:
9:00am EDT
Venue:
Virtual
Format:
Webcast — Corporate overview
Presenter:
Senior management
Webcast Link:
Information:
In addition, Chemomab reported that its corporate development team will be in Boston June 5-8, 2023, participating in the BIO International Convention’s One-on-One Partnering event. Registered attendees can click here to log in and schedule a meeting with Chemomab.